SCHEMBL30879043

SCHEMBL30879043

CC(C)[Si](C#Cc1cc(=O)n(-c2ccccc2)c2nc(Nc3ccc(N(C)CCCN(C)C)cc3)ncc12)(C(C)C)C(C)C

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
EGFR P00533 6/20 0.40
CDK4 P11802 5/20 0.40
CCND1 P24385 5/20 0.40
CCND2 P30279 4/20 0.40
CCND3 P30281 4/20 0.40
CCNT1 O60563 2/20 0.40
CDK9 P50750 2/20 0.40
GSK3B P49841 2/20 0.39
WEE1 P30291 1/20 0.38
FGFR4 P22455 1/20 0.37
TNK2 Q07912 2/20 0.37
BTK Q06187 1/20 0.37
FLT3 P36888 1/20 0.37
BLK P51451 1/20 0.37
LCK P06239 1/20 0.37
SRC P12931 1/20 0.37
KDR P35968 1/20 0.37
MAP4K1 Q92918 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30879096 0.95 EGFR (0.45) EGFRCDK4CCND1CCND2CCND3
SCHEMBL30878435 0.87 EGFR (0.43) EGFRCDK4CCND1CCND2CCND3
SCHEMBL30878693 0.87 CDK4 (0.49) EGFRCDK4CCND1CCND2CCND3
SCHEMBL30878942 0.85 EGFR (0.42) EGFRCDK4CCND1CCND2CCND3
SCHEMBL30879283 0.84 CCNT1 (0.45) EGFRCDK4CCND1CCND2CCND3
SCHEMBL30878419 0.82 EGFR (0.48) EGFRCDK4CCND1CCND2CCND3
SCHEMBL30879251 0.80 FGFR4 (0.46) EGFRCDK4CCND1CCND2CCND3
SCHEMBL30878988 0.80 CCND3 (0.51) EGFRCDK4CCND1CCND2CCND3
SCHEMBL30879056 0.80 CDK4 (0.47) EGFRCDK4CCND1CCND2CCND3
SCHEMBL30878783 0.79 CDK4 (0.51) EGFRCDK4CCND1CCND2CCND3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612148-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER Cancer Research Technology Limited (GB) 2025-09-10 EP disclosed
WO-2024094963-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-05-10 WO disclosed